Multiple Sclerosis Centre, Azienda Tutela Salute (ATS) Sardegna, University of Cagliari, Cagliari, Italy.
Front Immunol. 2021 Oct 6;12:728677. doi: 10.3389/fimmu.2021.728677. eCollection 2021.
Multiple Sclerosis (MS) is an inflammatory disease of the central nervous system. Sardinia, an Italian island, is one of the areas with the highest global prevalence of MS. Genetic factors have been widely explored to explain this greater prevalence among some populations; the genetic makeup of the Sardinians appears to make them more likely to develop autoimmune diseases. A strong association between MS and some infections have been reported globally. The most robust evidence indicating the role of infections is MS development concerns the Epstein-Barr virus (EBV). Anti-EBV antibodies in patients once infected by EBV are associated with the development of MS years later. These features have also been noted in Sardinian patients with MS. Many groups have found an increased expression of the Human endogenous retroviruses (HERV) family in patients with MS. A role in pathogenesis, prognosis, and prediction of treatment response has been proposed for HERV. A European multi-centre study has shown that their presence was variable among populations, ranging from 59% to 100% of patients, with higher HERV expression noted in Sardinian patients with MS. The (MAP) DNA and antibodies against MAP2694 protein were found to be associated with MS in Sardinian patients. More recently, this association has also been reported in Japanese patients with MS. In this study, we analysed the role of infectious factors in Sardinian patients with MS and compared it with the findings reported in other populations.
多发性硬化症(MS)是一种中枢神经系统的炎症性疾病。撒丁岛,意大利的一个岛屿,是全球多发性硬化症发病率最高的地区之一。遗传因素已被广泛探索,以解释某些人群中更高的发病率;撒丁岛人的基因构成似乎使他们更容易患上自身免疫性疾病。全球范围内已经报道了多发性硬化症与某些感染之间的强烈关联。最有力的证据表明感染在多发性硬化症的发展中起作用,涉及到 Epstein-Barr 病毒(EBV)。一旦感染 EBV 的患者体内的抗 EBV 抗体与多年后多发性硬化症的发展有关。这些特征也在撒丁岛多发性硬化症患者中得到了注意。许多研究小组发现,多发性硬化症患者体内的人类内源性逆转录病毒(HERV)家族表达增加。HERV 在发病机制、预后和治疗反应预测中的作用已被提出。一项欧洲多中心研究表明,它们在人群中的存在存在差异,从 59%到 100%的患者不等,在撒丁岛多发性硬化症患者中观察到更高的 HERV 表达。MAP 基因和针对 MAP2694 蛋白的抗体被发现与撒丁岛多发性硬化症患者有关。最近,这种关联也在日本多发性硬化症患者中得到了报道。在这项研究中,我们分析了传染性因素在撒丁岛多发性硬化症患者中的作用,并将其与其他人群的发现进行了比较。